Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024
-
New Guidelines on Use of Statins in HIV Care
Read the new guidelines on use of statins in New Guidelines for Use of Statins by People with HIV to Prevent Cardiovascular Events (HIV.gov blog, 2/29/24).News Article updated on 03/01/2024 -
National Clinician Consultation Center
-
Syphilis Cases Continue to Climb
Syphilis cases continue to climb in the U.S. In April 2023, CDC reported a 32% increase in cases from 2020 to 2021 (133,954 to 176.713 cases). In 2022, cases had jumped yet again, to 203,500.News Article updated on 03/04/2024 -
Keep Track of CROI 2024: HIV.gov Blogs
CROI 2024 is underway. Keep track via HIV.gov blogs.News Article updated on 03/05/2024 -
HepVu Map on Hep C, Opioids
New data on Hepatitis C and other health indicators are available on HepVu.News Article updated on 03/08/2024 -
CROI 2024 Highlights from HIV.gov
CROI 2024 highlights from HIV.gov:News Article updated on 03/07/2024 -
Rapid ART Program Initiative for New Diagnoses
Rapid ART Program Initiative for New Diagnoses (RAPID) was designed to connect people with a new HIV diagnosis to ART within five days of diagnosis and within one day of their initial care visit. Linkage navigators counseled people on HIV care, identified an available clinician capable of immediately prescribing ART, scheduled the clinical appointment, and connected people to additional support services. RAPID led to a reduction in median time between initial diagnosis and both ART initiation and viral suppression.Resource from the RWHAP Best Practices Compilation updated on 07/04/2024
-
YGetIt? Program
The YGetIt? Program engaged youth and young adults with HIV in care through three components: a health management mobile application (GET!), Peer Engagement Educator Professionals (PEEPs), and a graphic serial (Tested). Tested received over 200,000 views, and viral suppression rates among YGetIt? participants increased from 79% to 86% over the course of the program.Resource from the RWHAP Best Practices Compilation updated on 03/18/2024
-
National ADAP Formulary Database
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
-
National HIV PrEP Curriculum
Online learning portal for clinicians on pre-exposure prophylaxis (PrEP) for prevention of HIV.Resource updated 03/13/2024
-
Funding Opportunity: A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – DEMONSTRATION SYSTEMS (HRSA-24-107)
This HRSA HIV/AIDS Bureau pre-application webinar is for the funding opportunity, A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – Demonstration Systems (HRSA-24-107).Event updated 07/01/2024
-
Funding Opportunity: A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – EVALUATION AND TA PROVIDER (HRSA-24-108)
This HRSA HIV/AIDS Bureau pre-application webinar is for the funding opportunity, A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – EVALUATION AND TA PROVIDER (HRSA-24-108).Event updated 07/02/2024
-
INFINI-T
INFINI-T is a program designed to reach young transgender women of color with HIV and retain them in care through peer advocates who provided case management. These peer advocates facilitated social support sessions with the goal of alleviating the negative impacts of psychosocial factors like history of trauma, stigma, and discrimination. Clients were more likely to be virally suppressed and retained in care after 12 months of participating in the intervention.Resource from the RWHAP Best Practices Compilation updated on 07/11/2024
-
Funding Deadlines Near: Supporting a System-Level Syndemic Approach
Deadlines are fast approaching for several funding opportunities on innovations in HIV care under HRSA's Ryan
News Article updated on 07/09/2024 -
FDA Approves Point-of-Care HCV Test
FDA has approved a test for hepatitis C (HCV) that can deliver results within an hour, setting the stage for same-day test-and-treatment for HCV.News Article updated on 07/10/2024 -
OI Guidelines Update on Anal Cancer Screening
A panel of experts in HIV care has released new recommendations to prevent anal cancer for people with HIV, the first U.S. federal guidelines on the topic.News Article updated on 07/11/2024 -
SNAP: Status-Neutral, Whole-Person Approach
SNAP aims to advance whole person approaches to reduce disparities, prevent new HIV diagnoses, and improve health outcomes for communities disproportionately affected by HIV and related syndemics.RWHAP Technical Assistance Provider updated on 07/15/2024
-
Best Practices Compilation Continues to Grow
The Best Practices Compilation of tested HIV care interventions has added a new set of project innovations.Blog updated 07/15/2024
-
Keeping Track of Medicaid and Medicare: CMS Roundup
Keeping track of developments in Medicare and Medicaid (via the Centers for Medicare and Medicaid Services) is increasingly important for HIV care agencies.News Article updated on 07/15/2024